Sikcell: People living with Sickle Cell
We still Hope
November 2019 Blog Posts (1)
FDA approves voxelotor for sickle cell disease
On November 25, 2019, the Food and Drug Administration granted accelerated approval to voxelotor (Oxbryta, Global Blood Therapeutics) for adults and pediatric patients 12 years of age and older with sickle cell disease.
The primary efficacy outcome measure was Hb response rate defined as an Hb increase of >1 g/dL from baseline to week 24. The response rate for voxelotor was 51.1% (46/90) compared to 6.5% (6/92) in the placebo group (p<0.0001). Additional efficacy…
ContinueAdded by Ade Dotun on November 27, 2019 at 7:01pm — No Comments
Featured Blog Posts
Latest Blog Posts
- What does a cure mean to you campaign
- Penn Med SCD Contraception Study
- Taking Oxbryta? Want to be part of exciting research in SCD and make your voice heard?
- HAPPY World Sickle Cell Day 2022!
- Happy sickle cell awareness month! How are you celebrating?
- Sickle Cell Studies in Miami, Florida
- Sickle cell awareness month 2020!
Most Popular Blog Posts
Monthly Archives
2023
2022
2021
- May (2)
2020
2019
2018
2017
- February (1)
2016
2015
2014
2013
2012
- December (4)
- November (1)
- October (2)
- September (3)
- August (3)
- July (2)
- June (4)
- May (2)
- April (1)
- March (2)
- February (1)
- January (3)
2011
- December (3)
- November (1)
- October (9)
- September (3)
- July (5)
- June (1)
- May (5)
- April (5)
- March (4)
- February (5)
- January (7)
2010
- December (2)
- November (7)
- October (4)
- September (1)
- August (1)
- July (1)
- June (6)
- May (3)
- April (5)
- March (9)
- February (10)
- January (8)
2009
- December (23)
- November (13)
- October (19)
- September (16)
- August (16)
- July (12)
- June (3)
- May (3)
- April (6)
- March (2)
- February (1)
- January (5)
2008
Top Content
Notes
Events
Groups
© 2024 Created by Ade Dotun.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
